Burning Rock Biotech Files 2024 Annual 20-F Report

Ticker: BNR · Form: 20-F · Filed: Apr 29, 2025 · CIK: 1792267

Sentiment: neutral

Topics: 20-F, annual-report, biotech, financials

TL;DR

Burning Rock Biotech dropped its 2024 20-F, check financials for 12/31/24.

AI Summary

Burning Rock Biotech Ltd filed its annual 20-F report for the fiscal year ending December 31, 2024. The filing, submitted on April 29, 2025, provides comprehensive financial and operational details for the company, which is based in Guangzhou, Guangdong, China. It includes information on inter-company receivables/payables and various asset categories.

Why It Matters

This 20-F filing provides investors and stakeholders with a crucial update on Burning Rock Biotech's financial health and operational status for the past fiscal year, impacting investment decisions.

Risk Assessment

Risk Level: medium — As a foreign private issuer filing a 20-F, the company is subject to different reporting requirements than US domestic issuers, and its operations are based in China, which can introduce geopolitical and regulatory risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Burning Rock Biotech Ltd?

Burning Rock Biotech Ltd is classified under SERVICES-MEDICAL LABORATORIES [8071] according to its SIC code.

What is the company's SEC file number?

The SEC file number for Burning Rock Biotech Ltd is 001-39316.

Where is Burning Rock Biotech Ltd located?

The company's business and mailing address is NO. 5 XINGDAO RING ROAD NORTH, INTERNATIONAL BIO ISLAND, GUANGZHOU, GUANGDONG, 510005.

What specific asset categories are mentioned in the filing for the year ending December 31, 2024?

The filing mentions categories such as Common Class A, Common Class B, Parent Company Member, Electronic Equipment, Vehicles, Machinery and Laboratory Equipment, and Construction in Progress for the year ending December 31, 2024.

What does the filing indicate about inter-company balances?

The filing notes that inter-company receivables/payables represent balances of VIE and subsidiaries of the VIE due from/to the Company and the Group's consolidated subsidiaries.

Filing Details

This Form 20-F (Form 20-F) was filed with the SEC on April 29, 2025 regarding Burning Rock Biotech Ltd (BNR).

View full filing on EDGAR

View Full Filing

View this 20-F filing on SEC EDGAR

View on Read The Filing